根据该协议,Karveer有权在印度将公司的COVID药物NV-CoV-2和NV-CoV-2-R商业化。为了实现商业化,Karveer已经进行了临床开发和评估,并为此在印度赞助了这两种药物。
蹊之美股生物医药2021-09-23 23:00
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Aethlon Medical (NASDAQ:AEMD) +33%
Onconova Therapeutics (NASDAQ:ONTX) +28%
Dynavax Technologies (NASDAQ:DVAX) +26%
Candel Therapeutics (NASDAQ:CADL) +18%
BioCardia ...查看全文
蹊之美股生物医药2021-07-29 21:10
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Infinity Pharmaceuticals (NASDAQ:INFI) +62%
Tilray (NASDAQ:TLRY) +25%
Grove (NASDAQ:GRVI)+20%
NeuroMetrix (NASDAQ:NURO) +2%
成纤维细胞生长因子3是一种在多种肿瘤类型,尤...查看全文
智通财经APP获悉,NanoViricides(NNVC.US)周四表示,该公司已经开始研发对抗猴痘病毒的药物。受此消息提振,截至发稿,NanoViricides周四美股盘前暴涨47.97%,报3.64美元。 NanoViricides是一家基于新型纳米药物平台开发高效抗病毒疗法... 网页链接
$NanoViricides(NNVC)$ NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB Accession Number: 0001104659-19-064036 Act: 34 Size: 21 KB 网页链接
$NanoViricides(NNVC)$ RW - Registration Withdrawal Request Filed: 2019-11-06 AccNo: 0001104659-19-060199 Size: 80 KB 网页链接
$NanoViricides(NNVC)$ 8-K - Current report Filed: 2019-11-06 AccNo: 0001104659-19-060203 Size: 174 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$NanoViricides(NNVC)$ DEF 14A - Other definitive proxy statements Filed: 2019-10-28 AccNo: 0001104659-19-056946 Size: 1 MB 网页链接
$NanoViricides(NNVC)$ PRE 14A - Other preliminary proxy statements Filed: 2019-10-16 AccNo: 0001104659-19-054247 Size: 267 KB 网页链接
$NanoViricides(NNVC)$ S-1 - General form for registration of securities under the Securities Act of 1933 Filed: 2019-09-27 AccNo: 0001144204-19-046313 Size: 2 MB 网页链接
$NanoViricides(NNVC)$ 8-K - Current report Filed: 2019-09-26 AccNo: 0001144204-19-045967 Size: 49 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接
$NanoViricides(NNVC)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-08-23 AccNo: 0001144204-19-041547 Size: 8 MB 网页链接
$NanoViricides(NNVC)$ 8-K - Current report Filed: 2019-08-01 AccNo: 0001144204-19-037222 Size: 23 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial...
$NanoViricides(NNVC)$ 8-K - Current report Filed: 2019-06-10 AccNo: 0001144204-19-030343 Size: 206 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financia...